Stock listing

NASDAQ:ADAG Adagene, Inc. Stock

Follow Adagene, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:ADAG

$1.76 USD -0.06 (-3.3%)

Close on Nov 20, 2026

Past year -0.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$1.35 – $2.05 USDNov 20, 2026
Volume
1.37M sharesNov 20, 2026
Market cap
$118.2M USDAt the close on Nov 20, 2026 · price × 67.14M shares outstanding
52-week range
$1.27 – $4.85 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$824,939 USDMedian day 216,500 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Adagene, Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:ADAG · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.76-0.06-3.3%$2.00$2.05$1.351,371,420
$1.82+0.34+23.0%$1.48$1.95$1.481,295,036
$1.48-0.12-7.5%$1.51$1.82$1.2672,338,431
$1.60-0.11-6.4%$1.77$1.85$1.418945,089
$1.71-0.29-14.5%$1.96$1.96$1.70152,058
$2.00-0.13-6.1%$2.16$2.28$1.91278,107
$2.13+0.08+3.9%$2.036$2.42$1.96222,126
$2.05-0.07-3.3%$2.12$2.14$2.0185,678
$2.12+0.12+6.0%$2.10$2.27$2.08158,551
$2.00-0.02-1.0%$2.11$2.19$1.93189,025
$2.02-0.39-16.2%$2.24$2.24$2.005345,328
$2.41+0.06+2.6%$2.49$2.52$2.34114,829
$2.35+0.06+2.6%$2.25$2.535$2.25107,351
$2.29-0.22-8.8%$2.52$2.54$2.17181,777
$2.51-0.17-6.3%$2.67$2.69$2.4679,571
$2.68+0.01+0.4%$2.72$2.72$2.60172,571
$2.67+0.09+3.5%$2.75$2.78$2.61235,602
$2.58+0.09+3.6%$2.625$2.67$2.44189,230
$2.49+0.08+3.3%$2.42$2.55$2.3491,197
$2.41-0.03-1.2%$2.42$2.57$2.295167,165
$2.44+0.03+1.2%$2.385$2.50$2.275244,219
$2.41-0.09-3.6%$2.55$2.55$2.3995,527
$2.50+0.21+9.2%$2.30$2.50$2.3086,627
$2.29+0.23+11.2%$2.04$2.29$2.01306,389
$2.06-0.34-14.2%$2.40$2.40$2.01379,601
$2.40+0.11+4.8%$2.31$2.42$2.26552,483
$2.29-0.17-6.9%$2.35$2.50$2.25898,863
$2.46-0.28-10.2%$2.73$2.73$2.435228,500
$2.74-0.02-0.7%$2.77$2.855$2.68216,500
$2.76-0.02-0.7%$2.76$2.87$2.6251,649,300
$2.78-0.03-1.1%$2.80$3.10$2.71240,500
$2.81-0.12-4.1%$2.90$3.102$2.785173,100
$2.93+0.13+4.6%$2.82$3.02$2.82213,500
$2.80-0.05-1.8%$2.84$2.87$2.67325,700
$2.85-0.08-2.7%$2.96$3.00$2.80298,000
$2.93-0.27-8.4%$3.12$3.12$2.915278,300
$3.20-0.01-0.3%$3.18$3.35$3.00254,300
$3.21+0.01+0.3%$3.20$3.47$2.98492,300
$3.20+0.27+9.2%$2.94$3.21$2.87528,400
$2.93-0.05-1.7%$2.96$3.185$2.87196,900
$2.98+0.01+0.3%$2.94$3.01$2.81317,000
$2.97-0.26-8.0%$3.16$3.22$2.92208,000
$3.23+0.02+0.6%$3.31$3.338$3.215226,300
$3.21-0.10-3.0%$3.34$3.35$3.1897,800
$3.31-0.06-1.8%$3.37$3.505$3.171287,000
$3.37+0.20+6.3%$3.30$3.419$3.17260,600
$3.17+0.20+6.7%$3.00$3.237$2.92319,300
$2.97-0.30-9.2%$3.385$3.385$2.925626,100
$3.27-0.13-3.8%$3.38$3.60$3.235155,100
$3.40+0.09+2.7%$3.36$3.48$3.239258,600
$3.31+0.04+1.2%$3.54$3.552$3.20224,500
$3.27-0.22-6.3%$3.61$3.69$3.24267,500
$3.49-0.09-2.5%$3.55$3.61$3.45193,000
$3.58-0.11-3.0%$3.67$3.692$3.5628,100
$3.690.000.0%$3.71$3.85$3.56167,700
$3.69+0.05+1.4%$3.60$3.74$3.60102,700
$3.64+0.13+3.7%$3.51$3.675$3.42120,500
$3.51-0.17-4.6%$3.62$3.62$3.451131,600
$3.68-0.22-5.6%$3.89$3.89$3.66123,200
$3.90+0.05+1.3%$3.85$3.97$3.71296,200
$3.85+0.03+0.8%$3.97$4.09$3.82122,000
$3.82-0.08-2.1%$3.90$3.97$3.8063,072
$3.90-0.12-3.0%$3.99$4.005$3.795159,180
$4.02-0.07-1.7%$4.11$4.115$3.9761,300
$4.09-0.03-0.7%$4.11$4.18$4.01205,000
Ticker
NASDAQ:ADAG
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Adagene, Inc. news

Adagene, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
8 in the last 12 months · 10 in all · newest Nov 19, 2026 · oldest 2025
Decks
3 decks · latest September 2026

Valuation

EV/sales −0.5× against a median of 13.6×: 2nd lowest of 8 Biotechnology companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
−$3.65M USD
P/E
Loss
EV/sales
−0.5×
EV/EBITDA
Negative EBITDA
Price/book
1.1×
Gross margin
100.0%
Operating margin
−279.5%
Net margin
−229.6%
Debt to equity
0.1×
Beta vs S&P 500
1.43

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Adagene, Inc. · NASDAQ:ADAGUS$118.2M−US$3.65Mn/a−0.5×n/a1.1×−229.6%0.1×1.43
Invivyd, Inc. · NASDAQ:IVVDUS$122.0MUS$3.86Mn/a0.1×n/a0.8×−214.8%0.1×2.06
Satellos Bioscience Inc · TSX:MSCLUS$121.9MUS$69.24Mn/an/an/a2.5×n/a0.0×0.49
Alar Pharmaceuticals Inc · TPEX:6785US$121.0MUS$51.67Mn/a568×n/a1.7×n/a0.0×n/a
CANbridge Pharmaceuticals Inc. · HKEX:1228US$120.4MUS$111.5Mn/a13.4×n/an/a−146.4%n/an/a
STCube, Inc. · KRX:052020US$118.4MUS$72.43Mn/a13.6×n/a2.6×−338.7%0.0×n/a
Atrium Therapeutics, Inc. · NASDAQ:RNAUS$118.4M−US$113.0Mn/a−2.9×n/a0.6×−229.7%0.0×0.76
Curacle Co., Ltd. · KRX:365270US$117.6MUS$100.4Mn/a16.3×n/a3.4×−92.1%0.0×n/a
PegBio Co., Ltd. Class H · HKEX:2565US$117.2MUS$55.97Mn/an/an/a2.9×n/a0.0×n/a
enGene Therapeutics Inc. · NASDAQ:ENGNUS$116.6M−US$149.7Mn/an/an/a0.5×n/a0.0×1.82
Sinew Pharma, Inc. · TPEX:6634US$114.4MUS$84.23Mn/a59,064×n/a3.6×n/a0.0×n/a
Median of the othersUS$118.4MUS$62.60M13.6×2.5×−214.8%0.0×1.29

Forecasts

6 strong buy · Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.

Price target
9.91 USD · Analysts' mean
EPS, year to Dec 2026
-0.51 · 5 analysts
Revenue, year to Dec 2026
1.96M · 4 analysts

Team and board

Officers

OfficerRole
Peter LuoChairman of the Board of Directors
Man Kin TamChief Financial Officer
Alexander GoergenVice President, Head of Business Development
Guizhong LiuSenior Vice President of Early Drug Discovery
Jiping ZhaExecutive Vice President, Clinical Development
Kristine SheSenior Vice President, Head of Clinical Operations
Songmao ZhengSenior Vice President of Clinical Pharmacology and Quantitative Sciences
Wenlin ZengVice President of Early Stage CMC
Yan LiSenior Vice President, Bioinformatics and Information Technology
Ling ZhouExecutive Director, Head of Human Resources
Mickael Chane-DuChief Strategy Officer
Qinghai ZhaoChief Manufacturing Officer

Board

DirectorRole
Peter LuoChairman of the Board of Directors
Andy CheungIndependent Director
Cuong DoIndependent Director
Ling ZhouExecutive Director, Head of Human Resources
Man Kin TamChief Financial Officer
Ulf GrawunderIndependent Director
Zhu LiIndependent Director

Events

QuarterResultsShare move
Q1 2026Apr 1, 2026+1.8%
Quarter to Sep 30, 2025Dec 3, 2025−1.0%
Q2 2025Aug 12, 2025−27.9%
Quarter to Mar 31, 2025May 28, 2025+2.6%
Q4 2024Mar 24, 2025−2.7%
Q3 2024Nov 27, 2024+5.2%
Q2 2024Jul 25, 2024−7.9%
Q1 2024May 29, 2024+2.6%
Q4 2023Mar 29, 2024+15.7%
Q3 2023Nov 29, 2023+19.9%
All 20 quarters
QuarterResultsShare move
Q2 2023Aug 31, 2023 · After close+1.5%
Q1 2023Apr 28, 2023 · Before open+1.6%
Q4 2022Mar 28, 2023 · After close+4.1%
Q3 2022Nov 3, 2022 · After close+0.8%
Q2 2022Aug 30, 2022 · After close−0.7%
Q1 2022Apr 25, 2022 · After close+1.9%
Q4 2021Mar 31, 2022 · Before open−4.4%
Q3 2021Dec 1, 2021−5.1%
Q2 2021Aug 25, 2021 · After close−1.2%
Q1 2021Jun 2, 2021−2.4%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (September 2026)Investor deck34 slidesSeptember 2026
Investor Presentation (July 2023)Investor deck31 slidesJul 7, 2023
Investor Presentation (January 2022)Investor deck19 slidesJan 12, 2022

Open Decks

IPO

Priced at US$19.00 an ADS on Feb 8, 2021.

Price
US$19.00 an ADS
ADSs offered
7,354,000 American depositary shares
Offering size
US$139.7 million
Underwriters' option
Up to 1,103,100 more ADSs
Listing
ADAG on the Nasdaq Global Market
Underwriters
Goldman Sachs (Asia) L.L.C., Morgan Stanley, Jefferies, China Renaissance · In the order on the cover

Steps

StepWhen
Draft sent to the SEC in confidenceSep 22, 2020
Filed publiclyJan 19, 2021
Amended 3 timesNewest Feb 5, 2021
Shares registered with an exchangeFeb 3, 2021
Declared effective by the SECFeb 8, 2021
Final prospectus, with the priceFeb 10, 2021

Open IPO · From the cover of the final prospectus (424B4) filed Feb 10, 2021

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue7.67M103.2K18.1M9.29M10.2M700.9K480.0K1.51M
Cost of revenue582.6K926.2K
Gross profit7.67M-823.0K18.1M9.29M10.2M480.0K480.0K1.51M
Research and development22.0M28.8M36.6M81.3M68.1M33.5M16.2M16.1M
Selling, general and administrative7.08M7.27M8.67M11.9M14.4M3.44M3.44M2.77M
Operating income-21.4M-36.0M-23.7M-83.9M-72.4M-43.2M-19.2M-17.3M
Depreciation and amortization438.9K723.0K980.1K1.15M1.13M858.4K816.7K909.0K
EBITDA-21.0M-35.2M-22.7M-82.8M-71.2M-42.3M-18.4M-16.4M
Interest expense463.1K851.9K1.11M693.3K363.8K202.2K138.1K91.1K
Income before tax-17.9M-33.4M-17.3M-13.5M-17.0M-42.4M-16.4M-15.3M
Income tax-297.9K-17.6K1.69M459.1K1.70M3.16K861.6K-547.0K
Net income-17.6M-33.4M-18.9M-80.0M-73.2M-42.4M-16.4M-15.3M
Earnings per share, basic-0.30-0.59-0.35-1.48-1.46-2.67-1.10-0.94
Earnings per share, diluted-0.30-0.59-0.35-0.31-1.46-2.67-1.10-0.94

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents74.5M85.2M109.9M143.8M174.4M75.2M92.5M16.1M
Short-term investments00008.00M33.0M
Receivables17.3K8.31K222.0K619.4K3.00M132.4K480.0K1.43M
Inventory11
Current assets77.4M87.8M113.4M149.3M186.0M79.1M103.9M51.8M
Property, plant and equipment717.4K1.13M1.84M2.78M3.49M2.07M1.88M2.55M
Total assets78.3M89.3M115.7M152.4M189.5M84.3M105.9M54.4M
Accounts payable2.88M4.24M3.09M3.67M3.32M1.81M712.7K559.0K
Current liabilities25.2M38.2M31.5M55.1M29.8M16.1M7.18M10.3M
Long-term debt1.14M417.3K13.5M14.1M2.99M2.97M1.52M
Total debt6.12M18.2M21.9M27.8M7.49M7.98M2.56M2.33M
Total liabilities26.4M38.7M45.2M69.3M33.0M19.2M8.70M95.4M
Shareholders' equity35.3M50.5M70.6M83.1M156.6M-89.4M-57.0M-41.0M
Shares outstanding59.2M58.9M55.1M54.1M54.6M16.6M15.2M54.6M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations-15.7M-29.7M-28.5M-48.6M-43.4M-28.5M-18.2M-14.3M
Capital spending-17.1K-33.6K-85.0K-690.9K-2.51M-935.2K-151.8K-514.7K
Free cash flow-15.7M-29.7M-28.5M-49.3M-45.9M-29.5M-18.3M-14.8M
Cash from investing476.8K1.11M-77.4K-686.0K-2.51M7.07M24.9M-29.5M
Cash from financing4.45M3.77M-5.37M17.8M145.4M4.44M69.7M51.1M
Dividends paid-322.8K-4.61M
Share buybacks00-3.98M-2.36M0
Change in cash-10.7M-24.7M-33.8M-30.6M99.2M-17.4M76.5M7.32M

Open Financials

Filings

FilingDateTypeFiled with
6-K · Report of a foreign issuerNov 19, 2026Current reportSEC
6-K · Report of a foreign issuerNov 17, 2026Current reportSEC
6-K · Report of a foreign issuerNov 9, 2026Current reportSEC
4 · Change in ownershipOct 2, 2026Insider tradeSEC
4 · Change in ownershipSep 25, 2026Insider tradeSEC
6-K · Report of a foreign issuerSep 25, 2026Current reportSEC
6-K · Report of a foreign issuerSep 22, 2026Current reportSEC
4 · Change in ownershipSep 17, 2026Insider tradeSEC
6-K · Report of a foreign issuerSep 10, 2026Current reportSEC
6-K · Report of a foreign issuerSep 9, 2026Current reportSEC
All 194 filings
FilingDateTypeFiled with
144/A · Notice of proposed sale, amendedAug 20, 2026Other filingsSEC
144 · Notice of proposed saleAug 19, 2026Other filingsSEC
4 · Change in ownershipAug 18, 2026Insider tradeSEC
4 · Change in ownershipAug 17, 2026Insider tradeSEC
4 · Change in ownershipAug 17, 2026Insider tradeSEC
4 · Change in ownershipAug 17, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
4 · Change in ownershipAug 14, 2026Insider tradeSEC
6-K · Report of a foreign issuerAug 12, 2026Current reportSEC
4 · Change in ownershipAug 6, 2026Insider tradeSEC
6-K · Report of a foreign issuerJul 6, 2026Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedJun 8, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeMay 7, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerApr 17, 2026Current reportSEC
424B5 · ProspectusApr 2, 2026Offer documentSEC
6-K · Report of a foreign issuerApr 2, 2026Current reportSEC
424B5 · ProspectusApr 2, 2026Offer documentSEC
6-K · Report of a foreign issuerApr 2, 2026Current reportSEC
6-K · Report of a foreign issuerApr 1, 2026Current reportSEC
20-F · Annual reportApr 1, 2026Annual reportSEC
SCHEDULE 13G · Big-stake noticeMar 18, 2026Big-stake noticeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 17, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 29, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerJan 23, 2026Current reportSEC
EFFECT · Notice that a registration is effectiveJan 12, 2026Other filingsSEC
424B3 · ProspectusJan 9, 2026Offer documentSEC
CORRESP · Letter to the SECJan 7, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
6-K · Report of a foreign issuerNov 13, 2025Current reportSEC
F-3 · Registration statementOct 31, 2025Offer documentSEC
6-K · Report of a foreign issuerAug 12, 2025Current reportSEC
6-K · Report of a foreign issuerJul 15, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 2, 2025Big-stake noticeSEC
6-K · Report of a foreign issuerJul 1, 2025Current reportSEC
EFFECT · Notice that a registration is effectiveJun 2, 2025Other filingsSEC
424B5 · ProspectusMay 30, 2025Offer documentSEC
CORRESP · Letter to the SECMay 28, 2025Other filingsSEC
CORRESP · Letter to the SECMay 23, 2025Other filingsSEC
F-3/A · Registration statement, amendedMay 23, 2025Offer documentSEC
6-K · Report of a foreign issuerMay 22, 2025Current reportSEC
UPLOAD · Letter from the SECMay 21, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 12, 2025Big-stake noticeSEC
F-3 · Registration statementMay 9, 2025Offer documentSEC
20-F · Annual reportMar 24, 2025Annual reportSEC
6-K · Report of a foreign issuerMar 24, 2025Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedFeb 19, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 12, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeFeb 4, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 3, 2025Big-stake noticeSEC
6-K · Report of a foreign issuerJan 27, 2025Current reportSEC
SC 13G/A · Big-stake notice, amendedNov 7, 2024Big-stake noticeSEC
6-K/A · Report of a foreign issuer, amendedNov 7, 2024Current reportSEC
6-K/A · Report of a foreign issuer, amendedNov 7, 2024Current reportSEC
6-K · Report of a foreign issuerNov 7, 2024Current reportSEC
SCHEDULE 13G · Big-stake noticeSep 24, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerSep 16, 2024Current reportSEC
6-K · Report of a foreign issuerJul 25, 2024Current reportSEC
6-K · Report of a foreign issuerMar 29, 2024Current reportSEC
424B5 · ProspectusMar 29, 2024Offer documentSEC
20-F · Annual reportMar 29, 2024Annual reportSEC
6-K · Report of a foreign issuerMar 29, 2024Current reportSEC
SC 13D/A · Big-stake notice, amendedMar 1, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 9, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerFeb 9, 2024Current reportSEC
SC 13G · Big-stake noticeJan 19, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerJan 16, 2024Current reportSEC
6-K · Report of a foreign issuerNov 3, 2023Current reportSEC
6-K · Report of a foreign issuerSep 29, 2023Current reportSEC
6-K · Report of a foreign issuerAug 31, 2023Current reportSEC
UPLOAD · Letter from the SECJul 11, 2023Other filingsSEC
CORRESP · Letter to the SECJul 10, 2023Other filingsSEC
6-K · Report of a foreign issuerJul 7, 2023Current reportSEC
CORRESP · Letter to the SECJun 16, 2023Other filingsSEC
UPLOAD · Letter from the SECJun 5, 2023Other filingsSEC
6-K · Report of a foreign issuerMay 4, 2023Current reportSEC
6-K · Report of a foreign issuerApr 28, 2023Current reportSEC
20-F · Annual reportApr 28, 2023Annual reportSEC
6-K · Report of a foreign issuerApr 18, 2023Current reportSEC
6-K · Report of a foreign issuerMar 28, 2023Current reportSEC
SC 13D/A · Big-stake notice, amendedFeb 17, 2023Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 9, 2023Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 6, 2023Big-stake noticeSEC
6-K · Report of a foreign issuerJan 9, 2023Current reportSEC
6-K · Report of a foreign issuerDec 16, 2022Current reportSEC
6-K · Report of a foreign issuerNov 21, 2022Current reportSEC
6-K · Report of a foreign issuerSep 12, 2022Current reportSEC
6-K · Report of a foreign issuerAug 31, 2022Current reportSEC
6-K · Report of a foreign issuerJun 29, 2022Current reportSEC
EFFECT · Notice that a registration is effectiveMay 27, 2022Other filingsSEC
6-K · Report of a foreign issuerMay 26, 2022Current reportSEC
CORRESP · Letter to the SECMay 24, 2022Other filingsSEC
F-3/A · Registration statement, amendedMay 20, 2022Offer documentSEC
CORRESP · Letter to the SECMay 13, 2022Other filingsSEC
F-3/A · Registration statement, amendedMay 13, 2022Offer documentSEC
UPLOAD · Letter from the SECMay 6, 2022Other filingsSEC
DEL AMMay 2, 2022Other filingsSEC
SC 13D · Big-stake noticeApr 29, 2022Big-stake noticeSEC
F-3 · Registration statementApr 26, 2022Offer documentSEC
20-F · Annual reportApr 26, 2022Annual reportSEC
6-K · Report of a foreign issuerApr 8, 2022Current reportSEC
6-K · Report of a foreign issuerMar 31, 2022Current reportSEC
6-K · Report of a foreign issuerMar 16, 2022Current reportSEC
6-K · Report of a foreign issuerMar 9, 2022Current reportSEC
6-K · Report of a foreign issuerMar 2, 2022Current reportSEC
SC 13G · Big-stake noticeFeb 11, 2022Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 9, 2022Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 9, 2022Big-stake noticeSEC
6-K · Report of a foreign issuerFeb 3, 2022Current reportSEC
6-K · Report of a foreign issuerJan 27, 2022Current reportSEC
SC 13G · Big-stake noticeJan 26, 2022Big-stake noticeSEC
SC 13G · Big-stake noticeJan 26, 2022Big-stake noticeSEC
6-K · Report of a foreign issuerJan 19, 2022Current reportSEC
6-K · Report of a foreign issuerJan 13, 2022Current reportSEC
6-K · Report of a foreign issuerJan 12, 2022Current reportSEC
144/A · Notice of proposed sale, amendedDec 28, 2021Other filingsSEC
144 · Notice of proposed saleDec 27, 2021Other filingsSEC
6-K · Report of a foreign issuerDec 22, 2021Current reportSEC
6-K · Report of a foreign issuerDec 14, 2021Current reportSEC
6-K · Report of a foreign issuerDec 7, 2021Current reportSEC
6-K · Report of a foreign issuerDec 6, 2021Current reportSEC
6-K · Report of a foreign issuerNov 29, 2021Current reportSEC
6-K · Report of a foreign issuerNov 23, 2021Current reportSEC
6-K · Report of a foreign issuerNov 4, 2021Current reportSEC
6-K · Report of a foreign issuerOct 27, 2021Current reportSEC
6-K · Report of a foreign issuerAug 26, 2021Current reportSEC
6-K · Report of a foreign issuerAug 19, 2021Current reportSEC
6-K · Report of a foreign issuerAug 12, 2021Current reportSEC
6-K · Report of a foreign issuerJul 22, 2021Current reportSEC
6-K · Report of a foreign issuerJul 7, 2021Current reportSEC
6-K · Report of a foreign issuerMay 19, 2021Current reportSEC
20-F · Annual reportApr 28, 2021Annual reportSEC
S-8 · Registration statement for employee plansApr 15, 2021Offer documentSEC
6-K · Report of a foreign issuerApr 13, 2021Current reportSEC
6-K · Report of a foreign issuerMar 31, 2021Current reportSEC
6-K · Report of a foreign issuerMar 29, 2021Current reportSEC
6-K · Report of a foreign issuerMar 16, 2021Current reportSEC
SC 13G · Big-stake noticeFeb 19, 2021Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 19, 2021Big-stake noticeSEC
424B4 · ProspectusFeb 10, 2021Offer documentSEC
SEC STAFF LETTERFeb 9, 2021Other filingsSEC
EFFECT · Notice that a registration is effectiveFeb 9, 2021Other filingsSEC
EFFECT · Notice that a registration is effectiveFeb 9, 2021Other filingsSEC
CERT · Exchange's certificate of listingFeb 8, 2021Other filingsSEC
F-1/A · Registration statement, amendedFeb 5, 2021Offer documentSEC
CORRESP · Letter to the SECFeb 4, 2021Other filingsSEC
CORRESP · Letter to the SECFeb 4, 2021Other filingsSEC
CORRESP · Letter to the SECFeb 4, 2021Other filingsSEC
8-A12B · Registration of shares for listing on an exchangeFeb 3, 2021Other filingsSEC
CORRESP · Letter to the SECFeb 3, 2021Other filingsSEC
F-1/A · Registration statement, amendedFeb 3, 2021Offer documentSEC
UPLOAD · Letter from the SECFeb 1, 2021Other filingsSEC
CORRESP · Letter to the SECFeb 1, 2021Other filingsSEC
CORRESP · Letter to the SECFeb 1, 2021Other filingsSEC
CORRESP · Letter to the SECFeb 1, 2021Other filingsSEC
CORRESP · Letter to the SECFeb 1, 2021Other filingsSEC
F-1/A · Registration statement, amendedFeb 1, 2021Offer documentSEC
F-6Jan 29, 2021Other filingsSEC
UPLOAD · Letter from the SECJan 28, 2021Other filingsSEC
CORRESP · Letter to the SECJan 19, 2021Other filingsSEC
F-1 · Registration statementJan 19, 2021Offer documentSEC
UPLOAD · Letter from the SECDec 9, 2020Other filingsSEC
DRSLTR · Letter to the SEC with a draftNov 24, 2020Other filingsSEC
DRS/A · Draft registration statement, amendedNov 24, 2020Offer documentSEC
UPLOAD · Letter from the SECNov 12, 2020Other filingsSEC
DRSLTR · Letter to the SEC with a draftOct 27, 2020Other filingsSEC
DRS/A · Draft registration statement, amendedOct 27, 2020Offer documentSEC
SEC STAFF LETTEROct 21, 2020Other filingsSEC
UPLOAD · Letter from the SECOct 20, 2020Other filingsSEC
DRSLTR · Letter to the SEC with a draftSep 22, 2020Other filingsSEC
DRS · Draft registration statementSep 22, 2020Offer documentSEC

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Adagene, Inc.’s releases

Common shares
67,143,344
Fully diluted
67,143,344

Fully diluted

LineShares
Common shares67,143,344

Share count over time

CountShares
Nov 22, 202667,143,344

Open Cap table

Shareholders

HolderSharesOf the companyValueAs of
Janus Henderson6.67M9.9%US$21.3MSep 30, 2026
Deerfield Management Company, L.P.2.67M4.0%US$8.53MSep 30, 2026
Ameriprise1.72M2.6%US$5.49MSep 30, 2026
Squadron Capital Management LLC1.62M2.4%US$5.17MSep 30, 2026
HSG Holding Ltd1.34M2.0%US$4.3MSep 30, 2026
Flputnam Investment Management Co682K1.0%US$2.18MSep 30, 2026
Marshall Wace, LLP452K0.67%US$1.45MSep 30, 2026
Birchview Capital, LP430K0.64%US$1.38MSep 30, 2026
Siren, L.L.C.422K0.63%US$1.35MSep 30, 2026
Dauntless Investment Group, LLC283K0.42%US$905KSep 30, 2026
All 38 holders
HolderSharesOf the companyValueAs of
Moneta Group Investment Advisors LLC200K0.30%US$640KSep 30, 2026
Pathstone Holdings, LLC200K0.30%US$639KSep 30, 2026
Citadel106K0.16%US$339KSep 30, 2026
Renaissance Technologies90,7000.14%US$290KSep 30, 2026
Acadian Asset Management LLC84,8850.13%US$271KSep 30, 2026
Jane Street83,2140.12%US$266KSep 30, 2026
Two Sigma78,4310.12%US$251KSep 30, 2026
XTX Topco Ltd73,4930.11%US$235KSep 30, 2026
Millennium72,8420.11%US$233KSep 30, 2026
Invesco54,9480.08%US$176KSep 30, 2026
Walleye Capital LLC53,4480.08%US$171KSep 30, 2026
Exome Asset Management LLC52,5430.08%US$168KSep 30, 2026
UBS40,6900.06%US$130KSep 30, 2026
Geode Capital38,3530.06%US$123KSep 30, 2026
Kamunting Street Capital Management, L.P.38,0700.06%US$122KSep 30, 2026
SmartHarvest Portfolios, LLC31,8740.05%US$102KSep 30, 2026
Gsa Capital Partners LLP27,7820.04%US$89,000Sep 30, 2026
State Street27,4000.04%US$87,680Sep 30, 2026
RBC17,1610.03%US$55,000Sep 30, 2026
Hrt Financial LP12,6780.02%US$40,000Sep 30, 2026
Point72 Asset Management, L.P.10,0530.01%US$32,170Sep 30, 2026
JPMorgan9,3750.01%US$30,094Sep 30, 2026
Huntington National Bank2,464<0.01%US$7,885Sep 30, 2026
Morgan Stanley962<0.01%US$3,078Sep 30, 2026
BlackRock635<0.01%US$2,032Sep 30, 2026
Caitong International Asset Management Co., Ltd82<0.01%US$262Sep 30, 2026
Nisa Investment Advisors, LLC23<0.01%US$74Sep 30, 2026
SBI Securities Co., Ltd.13<0.01%US$42Sep 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Cuong Do
Other companies: BioVie Inc. (President & Chief Executive Officer · Since at least Jul 1, 2018); Spark I Acquisition Corp. (Director · Oct 5, 2023 – Oct 5, 2023 · Past); Merck & Company, Inc. (EVP & Chief Strategy Officer · Oct 3, 2011 – May 6, 2013 · Past); TE Connectivity plc (SVP, Corp. Strategy & Bus. Dev · Jun 16, 2010 – Sep 15, 2011 · Past)
Independent Director · Since at least Mar 18, 2026
Alexander GoergenVice President, Head of Business Development · Since at least Nov 5, 2026
Andy CheungIndependent Director · Since at least Nov 4, 2026
Guizhong LiuSenior Vice President of Early Drug Discovery · Since at least Nov 5, 2026
Jiping ZhaExecutive Vice President, Clinical Development · Since at least Nov 5, 2026
Kristine SheSenior Vice President, Head of Clinical Operations · Since at least Nov 5, 2026
Ling ZhouExecutive Director, Head of Human Resources · Since at least Mar 18, 2026
Li ZhuDirector · Since at least Mar 18, 2026
Man Kin TamChief Financial Officer · Since at least Nov 5, 2026
Mickael Chane-DuChief Strategy Officer · Since at least Mar 18, 2026
All 17 people
PersonSeat
Peter LuoChairman of the Board of Directors · Since at least Mar 18, 2026
Qinghai ZhaoChief Manufacturing Officer · Since at least Nov 5, 2026
Songmao ZhengSenior Vice President of Clinical Pharmacology and Quantitative Sciences · Since at least Nov 5, 2026
Ulf GrawunderIndependent Director · Since at least Mar 17, 2026
Wenlin ZengVice President of Early Stage CMC · Since at least Nov 5, 2026
Yan LiSenior Vice President, Bioinformatics and Information Technology · Since at least Nov 5, 2026
Zhu LiIndependent Director · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Adagene, Inc.